美瑞健康国际(02327.HK)拟1080万元收购雾化公司深圳龙舞8.3%股权
格隆汇9月4日丨美瑞健康国际(02327.HK)公告,2019年9月4日,公司通过其一家全资附属公司,签订了股权转让协议,向一位自然人收购深圳龙舞科技创新有限公司的8.3077%股权,收购对价为约人民币1080万元,此收购对价乃按照本公司同意对深圳龙舞增资6%之前深圳龙舞的上一轮融资的投资后估值即人民币1.3亿元计算得出的数字作为估值而得出。
收购完成后,该股权加上公司将根据增资协定认购的6%股权,将使本集团持有深圳龙舞约13.809231%的股权。此外,本集团有权进一步认购深圳龙舞不超过10%股权,如本集团全额行使该认购权,本集团将合计持有深圳龙舞(于本公司完成进一步认购10%股权后)经稀释后的股权约22.4283%(13.809231%的股权将被稀释到约12.4283%)。本集团将以内部资源支付相关收购代价。
深圳龙舞是一家旨在中国市场拓展雾化产品的创新性公司。本公司董事认为中国雾化产品市场快速增长,市场规模非常大,本公司通过入股深圳龙舞以参与在中国销售、推广雾化产品,将为本集团带来新的增长点。
公司称,未来本公司将持续布局、推进工业大麻业务发展,积极推动以大麻素为原料的药物研发和应用,加快布局大麻二酚健康消费品牌的投资和建设及工业大麻的全球化布局。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.